Mattifying Agents Market (2026 - 2036)

Mattifying Agents Market Forecast and Outlook 2026 to 2036

The mattifying agents market stood at USD 13.8 billion in 2025. Fact.MR estimates it will reach USD 14.5 billion in 2026 and expand to USD 25.2 billion by 2036. The market is projected to grow at a CAGR of 5.7% over the forecast period, supported by rising demand for multifunctional skincare and oil-control formulations.

The market is expected to generate an absolute dollar opportunity of USD 11.4 billion between 2026 and 2036. This growth trajectory is structurally supported by the convergence of rising adult acne prevalence, the skinification of cosmetics, and shifting consumer preferences toward hybrid products that both mattify and moisturise without compromising skin barrier function.

Dr. Noopur Jain, chief consultant dermatologist and founder, Skinzest says “Dermatologists see a clear rise in adult acne and oil-related concerns among urban consumers, and oil-control formulations are increasingly part of effective clinical skincare regimens,”

Country growth reflects adult acne demographics, urban humidity exposure, and local regulatory environments. China leads at 7.9% CAGR, supported by rising awareness of sebum management among Gen Z urban consumers. India follows at 7.5% driven by tropical climate conditions and expanding D2C skincare platforms. Germany registers 6.9% growth underpinned by EU cosmetics ingredient compliance investment. Brazil records 6.0% from expanding mass-market skincare penetration, while the United States posts 5.9% amid robust MoCRA-driven product reformulation cycles.

Market Definition

The mattifying agents market covers cosmetic ingredients and finished products designed to reduce sebum-induced shine on skin. It includes silica microspheres, kaolin clay, zinc oxide, and bio-derived seboregulators. It also covers creams, lotions, gels, and powders formulated for oil control. The core function is sebum absorption and light diffusion. End uses span mass cosmetics, prestige skincare, and dermatology-oriented products for oily, combination, and acne-prone skin.

Market Inclusions

The report provides global and regional revenue forecasts from 2026 to 2036. It is segmented by product form, skin type, distribution channel, and end user. Ingredient demand for silica, kaolin, zinc oxide, and bio-actives is analysed alongside finished formulations. Channels include online retail, specialty beauty stores, pharmacies, and supermarkets. Country coverage includes China, India, Germany, Brazil, and the United States.

Market Exclusions

The scope excludes cosmetic powders without oil-control intent. It omits sunscreen products unless they carry verified mattifying claims. Colour cosmetics such as foundations and concealers with incidental mattifying ingredients are not included. Industrial talc and silica outside personal care are excluded. The focus remains on purpose-formulated mattifying systems and enabling actives.

Research Methodology

• Primary Research: Interviews were conducted with formulation chemists, marketing heads, procurement managers, and specialty beauty buyers across North America, Europe, and Asia Pacific. These discussions validated pricing trends and ingredient adoption.
• Desk Research: Sources included FDA publications under MoCRA, EU Cosmetics Regulation updates, company annual reports, investor presentations, and product launch databases.
• Market Sizing and Forecasting: A hybrid approach was used. Top-down estimates assessed addressable demand by skin type and geography. Bottom-up inputs included average selling prices, replacement cycles, and first-purchase growth from distributor interviews.
• Data Validation and Update Cycle: Outputs were cross-checked against company earnings, regulatory filings, and retail sales data. Forecasts are reviewed annually to reflect regulatory and ingredient-level shifts.

Summary

• Market Definition
  • Mattifying agents are specialised personal care systems designed to absorb excess sebum and reduce shine. They include functional ingredients such as silica, kaolin, and zinc oxide, as well as creams, gels, lotions, and powders formulated for oily and acne-prone skin.
• Demand Drivers
  • Rising adult acne prevalence is expanding the addressable oily-skin population. Dermatologist recommendations and social media education are accelerating adoption.
  • Hybrid moisturizing-mattifying innovation is creating premium pricing tiers above basic powders. Bio-active seboregulators support barrier-friendly positioning.
  • Growth of D2C skincare platforms in India, China, and Southeast Asia is driving first-time adoption in humid urban markets where oil control is a key concern.
• Key Segments Analyzed
  • By Form: Mattifying Creams hold 36.5% share, driven by demand for dual hydration and oil control benefits. Lotions, gels, and powders follow.
  • By Skin Type: Oily Skin accounts for 48.3% of demand and is the fastest-growing segment. Combination, acne-prone, and sensitive skin segments follow.
  • By Distribution Channel: Online Retail is the fastest-growing channel, supported by D2C brands and algorithm-driven discovery. Supermarkets, specialty stores, and pharmacies remain core channels.
  • By End User: Women represent the largest segment. Men and unisex categories are growing faster as male grooming expands.
  • By Geography: Asia Pacific leads in volume growth due to humid climates and urbanisation. Europe leads in premium ingredient innovation under strict compliance rules.
• Analyst Opinion at FACT.MR
  • Shambhu Nath Jha, Principal Consultant at FACT.MR, opines, “CXOs will find this report critical for understanding how value is moving from legacy silica powders to bio-derived seboregulators and hybrid systems. Regulatory compliance under MoCRA and EU microplastic restrictions is raising entry barriers and strengthening scale advantages through 2036.”
• Strategic Implications
  • Ingredient suppliers should accelerate bio-derived seboregulator launches to replace synthetic micro plastic-linked materials under EU timelines.
  • Finished-product brands must strengthen MoCRA-compliant safety substantiation to maintain U.S. market access.
  • Distributors in India and China should partner with D2C-focused mattifying brands targeting humid climate oily-skin consumers with high repeat purchase rates.
• Methodology
  • Market sizing combined ingredient demand by skin type and geography with finished-product pricing data across forms and channels. Validation came from brand disclosures and distributor interviews.
  • Adoption trends were benchmarked against product launches from L’Oréal, Beiersdorf, Shiseido, Croda International, Foxtale, and major ingredient suppliers.
  • Regional forecasts incorporated acne prevalence data, humidity indices, regulatory timelines, and urban expansion statistics.

Drivers, Restraints, and Opportunities

Fact.MR estimates the mattifying agents market reached USD 13.8 billion in 2025, supported by persistently high oily-skin prevalence in tropical and urban populations. Oil-control has moved from a niche acne solution to a routine skincare step. In the U.S., pharmacy-led clinical skincare provides steady replacement demand. At the same time, dermatologist-backed routines in Asia Pacific and India are driving first-time purchases in markets where adult acne is a leading concern.

The market is splitting into two clear tiers. Commodity mineral powders such as kaolin and talc face pricing pressure from private labels and raw material commoditization. In contrast, biotech-driven seboregulators command premium pricing. Suppliers such as Croda Beauty Actives are expanding clinically supported portfolios that justify higher margins.

• Rising Oily Skin Incidence and Adult Acne Awareness: Oily and combination skin remain the most common global skin types. Adult acne affects around 15% of adult women and rising numbers of men. The American Academy of Dermatology reports growing consultation volumes among 25 to 40 year olds, reinforcing sustained demand for sebum-control formulations. [2]
• MoCRA Compliance Pressure as a Market Consolidator: The Modernization of Cosmetics Regulation Act introduced mandatory facility registration by July 2024 and adverse event reporting from December 2023, with GMP rules expected by December 2025. These requirements raise compliance costs and favour established producers with regulatory infrastructure, consolidating market share among well-capitalised brands. [3]
• EU Microplastic Restrictions and Ingredient Substitution Demand: The European Chemicals Agency restriction on intentionally added microplastics, phased from October 2023, is forcing reformulation of products using synthetic silica microspheres and nylon powders. This shift is increasing demand for natural minerals and bio-derived seboregulators from suppliers such as Imerys and Croda. [4]

Competitive Aligners for Market Players

The global mattifying agents market is moderately concentrated at the brand level and fragmented at the ingredient level. L'Oréal leads across mass and prestige segments through La Roche-Posay, Garnier, and L'Oréal Paris, which hold strong positions in oily and acne-prone skincare. Beiersdorf, Shiseido, Estée Lauder, Unilever, and Kenvue maintain broad international reach and pharmacy relationships. At the ingredient tier, Croda International and Imerys compete for reformulation mandates as brands respond to EU microplastic rules and U.S. MoCRA compliance cycles.

Structural advantage in this market comes from clinical validation and distribution depth. L'Oréal integrates digital diagnostics with product development, including its Cell BioPrint device introduced at CES 2025 and the Spotscan+Coach acne app launched in May 2025. These tools strengthen consumer trust before purchase. Croda Beauty Actives supports brands with biotech-based seboregulation ingredients, offering differentiation beyond mineral absorbents.

Pharmacy buyers increasingly require documented safety, GMP alignment, and adverse event reporting compliance under MoCRA. Established players secure preferred access to CVS and Walgreens shelves. D2C brands such as Foxtale compete by building credibility through strong repeat purchase and consumer data rather than pharmacy-led endorsement.

Recent Developments

• In January 2025, D2C skincare brand Foxtale raised USD 30 million in Series C funding from KOSÉ Corporation, Panthera Growth Partners, Z47, and Kae Capital, with proceeds directed at R&D expansion and Indian market penetration for oily and acne-prone skin formulations. [8]
• In May 2025, L'Oréal launched La Roche-Posay Spotscan+Coach, an AI-powered acne management app developed with dermatologists, targeting the clinical oily and acne-prone skin consumer and integrating directly with the brand's Effaclar and B5 mattifying skincare lines.

Scope of Report

Bibliography

• [1] L'Oréal Groupe. (May 2025). L'Oréal Unleashes Science, Technology and Creativity at Viva Technology 2025.
• [2] American Academy of Dermatology Association. (2024). Adult Acne Epidemiology and Consultation Volume Data. AAD Annual Meeting and Clinical Practice Data.
• [3] U.S. Food and Drug Administration. (2024). Modernization of Cosmetics Regulation Act of 2022 (MoCRA):
• [4] Imerys S.A. (September 2024). ImerCare Mineral Solutions for Skin Care: Mattifying, Exfoliation, and Oil Absorption Technical Bulletin.
• [5] L'Oréal Groupe. (March 2025). Statement on La Roche-Posay Effaclar Duo Reformulation and FDA Coordination. L'Oréal Investor Relations.
• [6] Croda International Plc. (September 2025). Croda Launches Zenakine Neuroactive Ingredient in Partnership with University of Manchester and SkinBiotherapeutics Plc.